Live

Heart
Failure

CARDIOLOGY SOLUTIONS

Heart Failure cost is 2-3 percent of total health-care expenditures in high-income countries and costs are projected to increase 200 percent in next 20 years world-wide. Current cost in the U.S. is $30.7 billion dollars.1 Congestive heart failure affects people of all ages, from children and young adults to the middle-aged and the elderly.
Time is critical for Heart Failure patients who present with cardiac issues. GE Healthcare's Cardiovascular IT and Diagnostic Cardiology solutions can provide insights throughout the cardiology care pathway to help improve clinical decisions and outcomes.

The Patient Journey

EARLY DETECTION

About half of people who develop heart failure die within five years of diagnosis.3 Important risk factors include HTN, DM, Metabolic Syndrome, and Coronary Artery Disease, but there are many other conditions that put patients at risk. Early identification and treatment of comorbidities can delay the onset of Heart Failure.4

Vivid™ E95/E90
Automated Function Imaging (AFI) 2.0

With the help of the artificial intelligence-based View Recognition feature, provides automated quantification of ejection fraction, left ventricular segmental and global longitudinal strain and other related parameters.


Vscan™ Extend
Bring ultrasound care into every setting in any environment.5


DIAGNOSIS & RISK ASSESSMENT

Diagnosis typically involves assessment for ECG abnormality and assessment of cardiac structure, function and possible cause. Guidelines suggest use of echocardiography due to its widespread availability, but other non-invasive imaging modalities can be used. In certain cases, invasive monitoring provides useful information for patients with persistent symptoms. Biomarkers provide helpful information about progression of disease.4

MAC™ resting ECG carts with 12SL™ Analysis
Decision support and predictive outcomes plus improved sensitivity through gender-specifc interpretation.

CARESCAPE™ Monitoring Portfolio
Diagnostic quality of 12SL™ analysis and initial interpretation, along with two-way integration to the MUSE™ cardiology information system for fast, validated access to patient's 12SL history and serial comparison.

ApexPro CH/FX Telemetry
Analyze ECG leads with EK-Pro algorithm to identify arrhythmias.

Discovery™ MI
Initial risk assessment through myocardial perfusion and cardiac flow reserve, while diagnostic CT allows complementary CT cardiovascular imaging.

SIGNA™ Works CV Imaging & Analysis Tools
A non invasive cardiac MR to assess cardiac morphology, function, flow, tissue viability and coronary anatomy without ionizing radiation.

Vivid™ Family Cardiac Ultrasound with Automated Quantification
Assess left ventricular function and cardiac performance with clarity, improving clinical confdence.

800 Series
Provides myocardial perfusion imaging in less than half the time of traditional technology using Evolution for Cardiac and SwiftScan acquisitions, with or without the added benefit of CT-based attenuation correction and the addition of Coronary Artery Calcium Scoring.

Discovery™ NM530c
Provides myocardial perfusion scans in as fast as three minutes, for the flexibility to choose between dose reduction, faster acquisitions or improved statistics.

TREATMENT AND INTERVENTION

Guidelines suggest lifestyle modifications, and use of specific medical therapies, such as ACE inhibitors and beta blockers. For certain patients not responding to medical therapies, guidelines suggest use of ICD or CRT. Revascularization and valve repair are used in certain stages of HF.4

Innova™ IGS 56
Enabling device implantation through enhanced visualization, workflow integration and lower dose by design.


CardioLab™ EP Recording System
Essential functionality. Exceptional performance. CardioLab™ provides efficient information integration to help drive clinical throughput in high-speed, high-volume labs.


PATIENT FOLLOW-UP AND MONITORING

Guidelines recommend regular follow up to assess severity and extent of left ventricular dysfunction, and development of a follow-up treatment strategy, including monitoring, to prevent acute decompensation and re-admission.4

GE Healthcare & Preventice Solutions
Providing in-hospital ECG, long-term Holter, Cardiac Event Monitoring (CEM) & Mobile Cardiac Telemetry (MCT) results into a single portal utilizing MUSE.


Discovery™ MI
Initial risk assessment through myocardial perfusion and cardiac flow reserve, while diagnostic CT allows complementary CT cardiovascular imaging.


SIGNA™ Works CV Imaging & Analysis Tools
A non invasive cardiac MR to assess cardiac morphology, function, flow, tissue viability and coronary anatomy without ionizing radiation.


Vivid™ Family Cardiac Ultrasound with Automated Quantification
Assess left ventricular function and cardiac performance with clarity, improving clinical confdence.


800 Series
Provides myocardial perfusion imaging in less than half the time of traditional technology using Evolution for Cardiac and SwiftScan acquisitions, with or without the added benefit of CT-based attenuation correction and the addition of Coronary Artery Calcium Scoring.


Discovery™ NM530c
Provides myocardial perfusion scans in as fast as three minutes, for the flexibility to choose between dose reduction, faster acquisitions or improved statistics.


DIGITAL FOUNDATION AND INNOVATIONS

Digital solutions, analytics and AI innovations such as GE Healthcare's Edison Platform, Muse and Centricity Cardio Enterprise connect our wing-to-wing technologies to practitioners for better cardiology outcomes, more efficiently.

MUSE™ ECG Management
By integrating with MUSE, data from home-based patients will be made available to clinicians on the same clinical workspace they use every day.


Centricity™ Cardio Enterprise2
Helps bridge the gaps between cardiovascular service lines with a single point of access.


REFERENCES
1. https://www.escardio.org/static_file/Escardio/Subspecialty/HFA/WHFA-whitepaper-15-May-14.pdf
2. Centricity Cardio Enterprise is comprised of Centricity Universal Viewer and Centricity Cardio WorkflowGE World Class Cardiac CT PPTX, 2017, slide 26 and https://www.gehealthcare.com/products/computed-tomography/revolution-family/revolution-ct, Smart Cardiac section.
3. Mozzafarian D, Benjamin EJ, Go AS, et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.
4. 2013 ACC guidelines Yancy et al. JACC Vol. 62, No. 16, 2013 2013 ACCF/AHA Heart Failure Guideline: Full Text October 15, 2013:e147–239.
5. The device has been verifed for limited use outside of professional healthcare facilities during transport. Use is restricted to environmental properties described in the user manual, please contact your GEHealthcare sales representative for detailed information.
6. This presentation refers to Innova IGS 520.